Table 2.
Underlying diseases and comorbidities
| Total | Initiation of invasive ventilation | |||
|---|---|---|---|---|
|
| ||||
| Number of FOB procedures | 169 | No | Yes | p |
|
| ||||
| 144 | 25 | |||
| Cardiovascular disease (%) | 65 (38) | 54 (38) | 11 (44) | 0.537 |
| Coronary artery disease | 29 (17) | 26 (18) | 3 (12) | 0.459 |
| COPD (%) | 26 (15) | 19 (13) | 7 (28) | 0.058 |
| CRPD (%) | 15 (9) | 12 (8) | 3 (12) | 0.552 |
| Immunosuppression (%) | 89 (53) | 71 (49) | 18 (72) | 0.036* |
| Hematological malignancy | 34 (20) | 25 (17) | 9 (36) | 0.023* |
| HIV | 21 (12) | 20 (14) | 1 (4) | 0.166 |
| Solid organ transplantation | 4 (2) | 3 (2) | 1 (4) | 0.561 |
| Solid cancer | 15 (9) | 13 (9) | 2 (8) | 0.975 |
| Corticosteroid therapy | 39 (23) | 31 (22) | 8 (32) | 0.251 |
| Immunosuppressive drugs | 25 (15) | 20 (14) | 5 (20) | 0.427 |
| Diabetes (%) | 24 (14) | 19 (13) | 5 (20) | 0.322 |
| Chronic renal failure (%) | 21 (15) | 16 (11) | 5 (20) | 0.182 |
| Neurological, swallowing impairment (%) | 20 (12) | 18 (13) | 2 (8) | 0.520 |
| Tobacco use (%) | 68 (40) | 55 (38) | 13 (52) | 0.194 |
| Anticoagulant therapy (%) | 31 (18) | 28 (19) | 3 (12) | 0.375 |
| Anti-platelet therapy (%) | 20 (12) | 17 (12) | 3 (12) | 0.978 |
Results are given either as number (percentages) or median (minimal and maximal values).
Abbreviations: FOB, fiberoptic bronchoscopy, HIV, positive serology for the human immunodeficiency virus., COPD: chronic obstructive pulmonary disease, CRPD, chronic restrictive pulmonary disease
*
p<0.05.